KIAA0195 Activators
The chemical class KIAA0195 Activators comprises chemicals that can engage in pathways known to influence vesicular transport and sorting mechanisms, thereby facilitating the role of KIAA0195 in these processes. Compounds like Forskolin serve to activate PKA, a critical enzyme for vesicular trafficking. By increasing PKA activity, the function of KIAA0195 within these transport mechanisms is bolstered. Likewise, Phorbol Myristate Acetate (PMA) stimulates PKC, resulting in the enhancement of membrane trafficking pathways that recruit KIAA0195 for their operations.
Certain chemicals act by modifying cellular states to induce vesicular trafficking. Ionomycin, for instance, alters intracellular calcium levels to activate vesicle pathways, thereby engaging KIAA0195. Thapsigargin operates on a similar principle by depleting ER calcium stores, eliciting an increase in vesicular transport that involves KIAA0195. The purpose of these activators is to engage specific cellular mechanisms and states that necessitate the activation of KIAA0195, thus facilitating its role in vesicle sorting and transport.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Elevates cellular cAMP levels, stimulating vesicular transport mechanisms that include KIAA0195. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $40.00 $129.00 $210.00 $490.00 $929.00 | 119 | |
Activates PKC, enhancing membrane trafficking pathways where KIAA0195 functions. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $94.00 $259.00 | 2 | |
Increases intracellular Ca2+ levels, which leads to the activation of vesicular pathways involving KIAA0195. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Depletes ER Ca2+ stores, necessitating increased vesicular transport involving KIAA0195. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $26.00 $92.00 $120.00 $310.00 $500.00 $908.00 $1821.00 | 46 | |
Tyrosine kinase activator that elevates endocytosis rates, implicating KIAA0195 in increased vesicle turnover. | ||||||
Alsterpaullone | 237430-03-4 | sc-202453 sc-202453A | 1 mg 5 mg | $67.00 $306.00 | 2 | |
CDK activator that shifts cellular focus to repair and maintenance, engaging KIAA0195 in vesicle sorting pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Activates the mevalonate pathway, which is linked to vesicular transport mechanisms involving KIAA0195. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $97.00 $254.00 | 36 | |
Activates the JNK pathway, which is known to interact with vesicular sorting processes where KIAA0195 is involved. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $159.00 $315.00 $598.00 | 34 | |
Phosphodiesterase inhibitor, raising cAMP levels and thus activating PKA-associated vesicular pathways with KIAA0195. | ||||||